Abstract
Recent results from the author's laboratory in the area of dihydropyrimidine chemistry are summarized.
Highlights
In recent years interest has focused on aza-analogs such as dihydropyrimidines of type 4 (DHPMs) which show a very
In this report we summarize our results in the area of dihydropyrimidine chemistry and present a literature survey on recent developments in this field
In the context of our computational studies on DHPM conformers we have developed synthetic methodology leading toward novel types of conformationally restricted dihydropyrimidine derivatives of type 11 that closely mimic the recently proposed receptor-bound conformation of DHP/DHPM calcium channel modulators shown in Figure 2 [26]
Summary
4-Aryl-1,4-dihydropyridines of the nifedipine type (DHPs, e.g 1-3) are the most studied class of organic calcium channel modulators and, since their introduction into clinical medicine in 1975, have become almost indispensable for the treatment of cardiovascular diseases such as hypertension, cardiac arrhythmias, or angina [1]. More than 20 years after the introduction of nifedipine (1), many DHP analogs have been synthesized and numerous second-generation commercial products have appeared on the market (e.g. 2, 3) [2]. In recent years interest has focused on aza-analogs such as dihydropyrimidines of type 4 (DHPMs) which show a very
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
